Showing 36,902 results

Filters
Sexually transmitted infections prevention

Heterosexual anal sex and first sexual exposure associated with high rates of HIV transmission in African youth

News
16 July 2004
Side effects

Nevirapine liver toxicity associated with CD4 percentage over 25% and genetic factors, rash alone with genetic factors only

News
16 July 2004
TB transmission & prevention

Isoniazid prophylaxis halves risk of death for children with HIV in South Africa

News
16 July 2004
Transmission & prevention

Citrus juices inactivate HIV; researcher defends investigation as possible microbicide

News
15 July 2004
Pregnancy and vertical transmission

Cumulative time on HAART increases health risks to both mother and foetus

News
15 July 2004
PEP

European study finds wasteful use of post-exposure prophylaxis

News
15 July 2004
HIV treatment

Thai nevirapine study reports final results

News
15 July 2004
Resistance

Drug resistant HIV present in quarter of gay men newly infected with HIV in England in 2002

News
14 July 2004
Treatment interruptions

CD4-guided treatment interruptions safe and cost-effective, Thai study shows

News
14 July 2004
HIV treatment

Treatment for children must become global priority, urges MSF

News
14 July 2004
Side effects

Low risk of serious kidney toxicity on tenofovir, but mild renal dysfunction cause for concern

News
14 July 2004

South African Medicines Control Council says don’t use nevirapine alone for mums to be

News
14 July 2004
Treatment interruptions

Pilot study finds weekend breaks from HAART may be possible on NNRTIs

News
14 July 2004
Treatment simplification strategies

Could monotherapy with Kaletra become an option for HIV treatment?

News
13 July 2004

IAS issue updated HIV treatment guidelines for rich countries

News
13 July 2004
Sexually transmitted infections prevention

Abstinence debate finds more consensus than difference

News
13 July 2004
Starting treatment

Initiating HAART with any one of four 3 x 5 drug choices leads to longest survival in San Francisco

News
13 July 2004
People with limited treatment options

Two-year data continue to show promise for T-20

News
13 July 2004
New & experimental HIV treatments

Once daily Reverset safe and effective over ten days in treatment-naïve and –experienced patients

News
12 July 2004
Starting treatment

Tenofovir has viral potency, a good lipid and safety profile, and should be available for first line HAART says study

News
12 July 2004
TB treatment

Efavirenz can be used at normal dose with rifampicin, Thais report

News
12 July 2004
HIV treatment

WHO: we are still on track for 3 x 5 HIV treatment goal

News
12 July 2004
Sexually transmitted infections tests & treatment

Taking HAART not associated with sexual risk taking, but belief that HAART makes HIV less infectious is, finds meta-analysis

News
12 July 2004
Sexually transmitted infections epidemiology

Azithromycin resistant syphilis found in HIV-positive gay men

News
9 July 2004